Tokuyama Corp - Company Profile
Powered by 
All the sales intelligence you need on Tokuyama Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Tokuyama Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Tokuyama Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Tokuyama Corp (Tokuyama) manufactures and sells chemicals, specialty products, and cement. The company’s product portfolio consists of soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, methylene chloride, chloroform, electronics materials, cement, and plastic window sashes among others. Its products find applications in industries such as electronics, healthcare, and environmental management. The company’s products are utilized in various fields, including the development of hydrogen production equipment and anion conductive membrane for water electrolyzer and H2 fuel cells. It has an operational presence across Japan, China, South Korea, Taiwan, Singapore, the US and Germany. Tokuyama is headquartered in Chiyoda-ku, Tokyo, Japan.
Headquarters
Japan
Address
5f, Front Place Akihabara, 1-7-5, Sotokanda, Chiyoda-Ku, Tokyo, 101-8618
Website
www.tokuyama.co.jp
Telephone
81 3 52072500
No of Employees
6,390
Industry
Chemicals
Ticker Symbol & Exchange
4043 (TYO)
Revenue (2025)
$2.2B
0.3%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
31.8%
(2025 vs 2024)
Market Cap*
$2.1B
Net Profit Margin (2024)
XYZ
31.4%
(2025 vs 2024)
* As of and is in US$
Products and Services
| Products | Brands |
|---|---|
| Chemicals: | Excelica |
| Caustic Soda | Tokuso Ipa |
| Calcium Chloride | Purifeed |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In September, the company entered into a partnership with Cognite to implement Cognite Data Fusion for enhanced digital transformation and operational efficiency in manufacturing. |
| 2025 | Plans/Strategy | In April, the company announced its plans to acquire the in vitro diagnostics and in vitro diagnostic pharmaceutical materials businesses from JSR Corporation. |
| 2024 | Contracts/Agreements | In July, the company entered into a memorandum of understanding with Suzuki Shokai Co., to launch a collaborative scheme for the recycling of used solar panels in Hokkaido, Japan. |
Competitor Comparison
| Key Parameters | Tokuyama Corp | Shin-Etsu Chemical Co Ltd | Sumitomo Chemical Co Ltd | Tosoh Corp | Nichias Corp |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Chiyoda-Ku | Chiyoda-Ku | Chuo-Ku | Chuo-Ku | Chuo-Ku |
| State/Province | Tokyo | Tokyo | Tokyo | Tokyo | Tokyo |
| No. of Employees | 6,390 | 27,274 | 29,279 | 14,813 | 6,373 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Hiroshi Yokota | Chairman | Executive Board | 2026 | 65 |
| Takahide Taniguchi | Director; General Manager-Cement Business Division; In charge of Cement, General Affairs & Human Resources and Procurement & Logistics; Managing Executive Officer | Executive Board | 2025 | 64 |
| Fumitetsu Iwasaki | General Manager - Research and Development Headquarters; General Manager - Life Sciences Division; Director - New Business, Research and Development, Kashima Plant Environment and Safety, and Advanced Technology | Executive Board | 2025 | 66 |
| Fumiaki Iwasaki | Senior Managing Executive Officer; Director | Executive Board | - | - |
| Tomohiro Inoue | President | Senior Management | 2026 | 62 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer